A prospective Study in 1041 patients with percutaneous endoscopic gastrostomy analysing different antithrombotic drug regimes concerning bleeding risk and other complications

Albert Ludwigs University Freiburg0 个研究点目标入组 1,000 人开始时间: 2008年4月14日最近更新: 2020年1月13日

试验速览

暂无简介。

•All 1057 patients referred between September 2001 and March 2007 to the endoscopic department of the Surgical Hospital at the University of Freiburg from in-house or external specialist departments (Neurology, Radiology, Clinic for Anesthesia, Cardiac Surgery and Orthodontic Surgery, ENT and Pediatrics and the International Medical Service -IMS) with the indication for percutaneous endoscopic gastrostomy (PEG) were enrolled according to predefined exclusion criteria
•further criteria
•diabetes mellitus
•coagulopathy
•neurological disorders
•inflammatory disorders
•radiation therapy
•chemo therapy
•ENT: Esopageal-Naso-Throat Hospital

•The following exclusion criteria were defined: Patients in whom no standard pull-through” technique with or without prior Savary-Gilliard bouginage (SG-bouginage) in stenosis of the hypopharynx or esophagous was possible, patients in whom the PEG could not be placed without additional imaging (computer tomography), and patients in whom PEG placement had to be terminated prior to completion due to respiratory or other complications, or patients who died within the first 7 days.

发起方

Albert Ludwigs University Freiburg